Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF‐targeted therapies

Publisher： John Wiley & Sons Inc

E-ISSN： 2045-7634|2045-7634|10|1461-1471

ISSN： 2045-7634

Source： Cancer Medicine, Vol.2045-7634, Iss.10, 2015-10, pp. : 1461-1471

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential response to EGFR- and VEGF-targeted therapies in patient-derived tumor tissue xenograft models of colon carcinoma and related metastases

By                

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 583-588

Spandidos Publications

Access to resources Recommend Favorite

The evolving role of VEGF-targeted therapies in the treatment of metastatic colorectal cancer

By Fakih Marwan  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 4, 2013-04 ,pp. : 427-438

Informa Healthcare

Access to resources Recommend Favorite

Associations Between Genetic Polymorphisms of Epidermal Growth Factor Receptor (EGFR) and Survival of Colorectal Cancer (CRC) Patients Treated with 5-Fluorouracil-Based Chemotherapy

By Lai Ching-Yu   Sung Fung-Chang   Hsieh Ling-Ling   Tang Reiping   Chiou Hung-Yi   Wu Fang-Yang   Yeh Chih-Ching  

Annals of Surgical Oncology, Vol. 20, Iss. 3, 2013-12 ,pp. : 599-606

Springer Publishing Company

Access to resources Recommend Favorite

Do Research Perspectives Exist for Further Anti-EGFR Targeted Therapies in Patients with Breast Cancer?

By Theohari Irini  

The Journal of OncoPathology, Vol. 1, Iss. 1, 2013-04 ,pp. : 15-19

Optimal Clinical Ltd

Access to resources Recommend Favorite

Role of five small nucleotide polymorphisms in the VEGF gene on the susceptibility to osteosarcoma and overall survival of patients

By        

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1481-1486

Spandidos Publications

Access to resources Recommend Favorite